However, we found that tumors associated with BRCA1 mutations demonstrate heterogeneity in protein expression, and thus bulk sequencing, promoter methylation and LOH analysis may mask sub-populations of tumor cells that vary in regards to BRCA1 locus-specific LOH. The gene discussed is BRCA1; the disease is neoplasm.